Weng's lab
Research Field
Jui-Hsia Weng Ph.D. joined the Institute of Biological Chemistry, Academia Sinica, as an Assistant Research Fellow in late 2021 and holds a joint appointment as Assistant Professor at the Institute of Biochemical Sciences, National Taiwan University. Her research focuses on how small molecules regulate whole-organism physiology, with an emphasis on developing strategies to mitigate dysregulated inflammation, a central feature of many chronic diseases.
The Weng Lab is particularly interested in liver-derived signaling molecules, hepatokines, and their roles in coordinating immune and metabolic responses under both physiological and pathological conditions. By exploring how hepatokines drive systemic adaptation, the lab seeks to identify molecular pathways that could inspire the development of innovative therapeutic strategies. To pursue these goals, the lab integrates chemical probes, cellular systems, pre-clinical animal models, and patient-derived evidence. Through this multidisciplinary framework, the lab aims to translate fundamental molecular discoveries into tangible advances for human health.
We explore how inflammation and appetite are controlled, aiming to develop new strategies to treat obesity and inflammatory diseases. Our research focuses on: 1. Immunotherapy and metabolic regulation; 2. Anti-Obesity Drug Development; 3. Multi-Omics and Precision Medicine.
# Excellent Young Scholars @ 2025 NSTC 2030 cross-generation young scholars program
# Honorable mention @ 2020 Porter Prizes for Research Excellence Award
Ph.D., Biochemistry and Molecular Biology, Yang-Ming University, Taiwan